Enarodustat ( JTZ-951 ) is an orally-active HIF-PH inhibitor with an EC50 of 0.22 Μm, that promotes erythropoiesis by accelerating the endogenous production of erythropoietin (EPO) and controlling the expression of molecules responsible for iron metabolism. The Phase 3 clinical studies confirmed efficacy in anemic patients with non-dialysis dependent CKD and dialysis dependent CKD. Furthermore, the favorable tolerability profile on safety of enarodustat was obtained during the studies
For research use only. We do not sell to patients.
Name | Enarodustat ( JTZ-951 ) |
---|---|
Iupac Chemical Name | N-[7-hydroxy-5-(2-phenylethyl)[1,2,4]triazolo[1,5-a]pyridine-8-carbonyl]glycine |
Synonyms | Enarodustat ; JTZ-951 ; JTZ 951 ; JTZ951 ; |
Molecular Formula | C17H16N4O4 |
Molecular Weight | 340.33 |
Smile | O=C(O)CNC(C1=C(O)C=C(CCC2=CC=CC=C2)N3C1=NC=N3)=O |
InChiKey | NALAUGMPMIVAOW-UHFFFAOYSA-N |
InChi | InChI=1S/C17H16N4O4/c22-13-8-12(7-6-11-4-2-1-3-5-11)21-16(19-10-20-21)15(13)17(25)18-9-14(23)24/h1-5,8,10,22H,6-7,9H2,(H,18,25)(H,23,24) |
CAS Number | 1262132-81-9 |
Related CAS | 1262132-81-9 |
Packaging | Price | Availability | Purity | Shipping Time |
---|---|---|---|---|
Bulk | Enquiry | Enquiry | Enquiry |
Formulation | 类白色固体 |
---|---|
Purity | 98% Min. |
Storage | 短期可在0-4度保存,数天至数月;长期可在-20度保存三年。 |
Solubility | 可溶于DMSO;不溶于水 |
Handling | Avoid inhalation, contact with eyes and skin. Avoid dust and aerosol formation. Use only in areas with appropriate exhaust ventilation. |
Shipping Condition | 作为非危险化学品在环境温度下装运。这种产品在正常运输和海关工作期间可以稳定几周 |
HS Code | 2933599090 |
Targets | |
---|---|
Mechanism | |
Cell study | |
Animal study | |
Clinical study |